Europe Peptide Therapeutics Market Size & Outlook

The peptide therapeutics market in Europe is expected to reach a projected revenue of US$ 43,925.4 million by 2030. A compound annual growth rate of 10.1% is expected of Europe peptide therapeutics market from 2024 to 2030.
Revenue, 2023 (US$M)
$21,320.7
Forecast, 2030 (US$M)
$43,925.4
CAGR, 2024 - 2030
10.1%
Report Coverage
Europe

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

Europe peptide therapeutics market, 2018-2030 (US$M)

Europe peptide therapeutics market, 2018-2030 (US$M)

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

Europe peptide therapeutics market highlights

  • The Europe peptide therapeutics market generated a revenue of USD 21,320.7 million in 2023.
  • The market is expected to grow at a CAGR of 10.9% from 2024 to 2030.
  • In terms of segment, metabolic disorders was the largest revenue generating application in 2023.
  • Metabolic disorders is the most lucrative application segment registering the fastest growth during the forecast period.
  • Country-wise, Norway is expected to register the highest CAGR from 2024 to 2030.


Europe data book summary

Market revenue in 2023USD 21,320.7 million
Market revenue in 2030USD 43,925.4 million
Growth rate10.9% (CAGR from 2023 to 2030)
Largest segmentMetabolic disorders
Fastest growing segmentMetabolic disorders
Historical data covered2018 - 2022
Base year for estimation2023
Forecast period covered2024 - 2030
Quantitative unitsRevenue in USD million
Market segmentationCancer, Metabolic disorders, Cardiovascular disorders, Respiratory disorders, Gastrointestinal disorders, Infectious disease, Pain, Dermatological disorders, Neurological disorders, Renal disorders
Key market players worldwideEli Lilly and Co, Pfizer Inc, Amgen Inc, Takeda Pharmaceutical Co Ltd, AstraZeneca PLC, Teva Pharmaceutical Industries Ltd, Sanofi SA, Roche Holding AG, Novartis AG ADR, Novo Nordisk A/S ADR, GlaxoSmithKline, Ironwood Pharmaceuticals Inc Class A, Ipsen SA, Radius Health


Other key industry trends

  • In terms of revenue, Europe region accounted for 22.7% of the global peptide therapeutics market in 2023.
  • Globally, North America is projected to lead the regional market in terms of revenue in 2030.
  • North America is the fastest growing regional market and is projected to reach USD 172,089.8 million by 2030.

Metabolic disorders was the largest segment with a revenue share of 59.44% in 2023. Horizon Databook has segmented the Europe peptide therapeutics market based on cancer, metabolic disorders, cardiovascular disorders, respiratory disorders, gastrointestinal disorders, infectious disease, pain, dermatological disorders, neurological disorders, renal disorders covering the revenue growth of each sub-segment from 2018 to 2030.


Europe held the second-largest market share in 2023 after North America and is estimated to grow at a lucrative CAGR over the forecast period. This growth can be attributed to increased research funding and the presence of key market players in this region. Increasing investments are driving the number of biopharmaceutical companies in Europe. 

This population is at a relatively high risk of developing various target diseases, including cancer, cardiovascular diseases, & neurological disorders, as the risk of developing these conditions and hospitalization rates are relatively higher in elderly patients. Thus, owing to the abovementioned factors, the region is expected to witness exponential growth opportunities during the forecast period.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Peptide Therapeutics Market Companies

Name Profile # Employees HQ Website
Radius Health View profile 251-500 Cambridge, Massachusetts, United States, North America http://www.radiuspharm.com
Ironwood Pharmaceuticals Inc Class A View profile 267 100 Summer Street, Suite 2300, Boston, MA, United States, 02110 https://www.ironwoodpharma.com
GlaxoSmithKline View profile 10001+ London, England, United Kingdom, Europe http://www.gsk.com
Ipsen SA View profile 5325 65 Quai Georges Gorse, Billancourt Cedex, Boulogne, France, 92100 https://www.ipsen.com
Takeda Pharmaceutical Co Ltd View profile 49095 1-1, Nihonbashi-Honcho 2-Chome, Chuo-ku, Tokyo, Japan, 103-8668 https://www.takeda.com
AstraZeneca PLC View profile 89900 1 Francis Crick Avenue, Cambridge Biomedical Campus, Cambridge, United Kingdom, CB2 0AA https://www.astrazeneca.com
Novo Nordisk A/S ADR View profile 66015 Novo Alle 1, Bagsvaerd, Denmark, 2880 https://www.novonordisk.com
Eli Lilly and Co View profile 43000 Lilly Corporate Center, Indianapolis, IN, United States, 46285 https://www.lilly.com
Roche Holding AG View profile 103605 Grenzacherstrasse 124, Basel, Switzerland, 4070 https://www.roche.com
Sanofi SA View profile 87994 46, avenue de la Grande Armée, Paris, France, 75017 https://www.sanofi.com
Pfizer Inc View profile 88000 66 Hudson Boulevard East, New York, NY, United States, 10001-2192 https://www.pfizer.com
Amgen Inc View profile 26700 One Amgen Center Drive, Thousand Oaks, CA, United States, 91320-1799 https://www.amgen.com
Teva Pharmaceutical Industries Ltd View profile 37851 124 Dvora HaNevi’a Street, Tel Aviv, Israel, 6944020 https://www.tevapharm.com
Novartis AG ADR View profile 76057 Lichtstrasse 35, Basel, Switzerland, 4056 https://www.novartis.com

Europe peptide therapeutics market size, by country, 2018-2030 (US$M)

Europe Peptide Therapeutics Market Outlook Share, 2023 & 2030 (US$M)

Europe peptide therapeutics market size, by country, 2018-2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more
Chat with us
Research Assistance
Online